Literature DB >> 5416393

The separation of nine components and two inactivators of components of complement in humansserum.

D H Vroon, D R Schultz, R M Zarco.   

Abstract

Mesh:

Substances:

Year:  1970        PMID: 5416393     DOI: 10.1016/0019-2791(70)90029-7

Source DB:  PubMed          Journal:  Immunochemistry        ISSN: 0019-2791


× No keyword cloud information.
  20 in total

1.  Antibody-independent binding of complement component C1q by Legionella pneumophila.

Authors:  C S Mintz; P I Arnold; W Johnson; D R Schultz
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

2.  Mechanisms of lysosomal enzyme release from human leukocytes: microtubule assembly and membrane fusion induced by a component of complement.

Authors:  I Goldstein; S Hoffstein; J Gallin; G Weissmann
Journal:  Proc Natl Acad Sci U S A       Date:  1973-10       Impact factor: 11.205

3.  Relationships between the haemolytic activities of the human complement system and complement components.

Authors:  A Takada; Y Imamura; Y Takada
Journal:  Clin Exp Immunol       Date:  1979-02       Impact factor: 4.330

4.  Conversion of the fourth complement component studied by crossed immunoelectrophoresis.

Authors:  A G Sjöholm; A B Laurell
Journal:  Clin Exp Immunol       Date:  1973-08       Impact factor: 4.330

5.  Suramin--a potent reversible and competitive inhibitor of complement systems.

Authors:  J S Fong; R A Good
Journal:  Clin Exp Immunol       Date:  1972-01       Impact factor: 4.330

6.  Fluid phase destruction of C2 hu by C1 hu. 3. Changes in activity for synthetic substrates upon cell binding, heat inactivation and interaction with C1INH.

Authors:  M Kondo; I Gigli; K F Austen
Journal:  Immunology       Date:  1972-03       Impact factor: 7.397

7.  The in vivo behaviour of complement-coated red cells: studies in C6-deficient, C3-depleted and normal rabbits.

Authors:  D L Brown; P J Lachmann; J V Dacie
Journal:  Clin Exp Immunol       Date:  1970-09       Impact factor: 4.330

8.  Inactivation of C1 in rheumatoid synovial fluid, purfied C1 and C1 esterase, by gold compounds.

Authors:  D R Schultz; J E Volanakis; P I Arnold; N L Gottlieb; K Sakai; R M Stroud
Journal:  Clin Exp Immunol       Date:  1974-07       Impact factor: 4.330

9.  In vitro activation of C1s in plasma of patients with hereditary angioneurotic oedema.

Authors:  S Shafiasghar; R H Cormane; K W Pondman
Journal:  Clin Exp Immunol       Date:  1976-08       Impact factor: 4.330

10.  Purification of soluble immune complexes from serum using polymethylmetacrylate beads coated with conglutinin or C1q. Application to the analysis of the components of in vitro formed immune complexes and of immune complexes occurring in vivo during leishmaniasis.

Authors:  P Casali; P H Lambert
Journal:  Clin Exp Immunol       Date:  1979-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.